LENZ- Lenz Therapeutics, Inc.

Name: Lenz Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Lenz Therapeutics, Inc. (LENZ) has 12 insiders with recent SEC Form 4 filings, including 6 buys and 30 sells. LENZ is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Versant Venture Capital Vi, L.P.	764.3K	$7.69M	-
Other	Odrich Marc	84.2K	$847.1K	-
CEO	Schimmelpennink Evert B.	77.3K	$777.5K	-
Other	Olsson Shawn	14.0K	$140.8K	-
10%	Ra Capital Management, L.P.	13.5K	$135.8K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 27, 2026	George Jeffrey P.	Director	Buy	5,592	$8.92	$49,890.15	New	-	-
Mar 27, 2026	Chevallard Daniel R.	Chief Financial Officer	Buy	7,500	$8.57	$64,275.00	+139.2%	-	-
Mar 27, 2026	Schimmelpennink Evert B.	President, CEO And Secretary	Buy	28,089	$8.95	$251,410.59	+57.1%	-	-
Nov 17, 2025	Olsson Shawn	Chief Commercial Officer	Sale+OE	10,000	$26.10	$261,022.18	-39.6%	-49.3%	-
Nov 7, 2025	McCollum James W	Director	Buy	10,500	$22.79	$239,278.20	New	-39.2%	-
Nov 7, 2025	Chevallard Daniel R.	Chief Financial Officer	Buy	2,198	$22.76	$50,016.99	+34.4%	-39.2%	-
Sep 30, 2025	Versant Venture Capital Vi, L.P.64	10% Owner	Sell	224,974	$46.01	$10,352,017.45	-3.9%	-64.5%	-
Sep 18, 2025	Versant Venture Capital Vi, L.P.64	10% Owner	Sell	135,304	$42.23	$5,714,356.00	-2.1%	-60.7%	-
Aug 26, 2025	Versant Venture Capital Vi, L.P.64	10% Owner	Sell	188,094	$39.47	$7,423,920.06	-1.4%	-17.3%	-
Aug 18, 2025	Versant Venture Capital Vi, L.P.64	10% Owner	Sell	260,713	$39.34	$10,255,243.56	-5.2%	-33.7%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC